Crowdfunding triggers Capital Increase of 800,000 Euros at Rodos Biotarget
First, impact investing in the area of health economy will be opened up also for private investors within their bounds of possibilities. Second, the company wants to access business partners, collaborators, customers, and private equity through the level of attention created by crowdfunding. This has been achieved with the company entry of medical entrepreneur Otto H. Gies.
This financing round is further accompanied by High-Tech Gründerfonds and Hannover Investimpuls Fonds.
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.